US Stock MarketDetailed Quotes

FUSN Fusion Pharmaceuticals

Watchlist

21.550
0.0000.00%

Close Jun 4 16:00 ET

1.83BMarket Cap-15392P/E (TTM)

Fusion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

41.55%2.07M

1,108.43%2.01M

-94.04%34K

-95.21%28K

1.46%1.46M

-76.43%140K

-48.92%166K

9.40%570K

Operating revenue

--0

41.55%2.07M

--0

1,108.43%2.01M

-94.04%34K

-95.21%28K

1.46%1.46M

-76.43%140K

-48.92%166K

9.40%570K

Cost of revenue

Gross profit

Operating expense

44.11%35.86M

13.19%101.3M

15.14%28.28M

-10.75%21.4M

34.70%26.75M

17.87%24.88M

7.24%89.5M

35.32%24.56M

20.82%23.97M

-28.54%19.86M

Selling and administrative expenses

61.54%14.55M

1.95%31.2M

9.76%7.63M

-8.22%6.81M

-0.36%7.75M

6.59%9.01M

12.92%30.6M

9.69%6.95M

3.69%7.42M

17.15%7.78M

-General and administrative expense

61.54%14.55M

1.95%31.2M

9.76%7.63M

-8.22%6.81M

-0.36%7.75M

6.59%9.01M

12.92%30.6M

9.69%6.95M

3.69%7.42M

17.15%7.78M

Research and development costs

34.23%21.31M

19.03%70.1M

17.27%20.65M

-11.88%14.59M

57.29%18.99M

25.40%15.88M

4.50%58.9M

49.07%17.61M

30.49%16.55M

-42.89%12.08M

Operating profit

-44.28%-35.86M

-12.72%-99.23M

-15.80%-28.28M

18.55%-19.39M

-38.50%-26.71M

-21.10%-24.86M

-7.34%-88.03M

-39.10%-24.42M

-21.98%-23.81M

29.27%-19.29M

Net non-operating interest income expense

137.25%1.66M

1,111.11%4.36M

582.86%956K

685.79%1.49M

2,388.68%1.21M

740.96%698K

-5.51%360K

72.84%140K

77.57%190K

-154.64%-53K

Non-operating interest income

82.61%3.51M

340.81%9.53M

75.23%2.29M

392.66%2.82M

1,160.10%2.5M

2,214.46%1.92M

467.19%2.16M

1,514.81%1.31M

434.58%572K

--198K

Non-operating interest expense

51.43%1.85M

186.84%5.17M

14.38%1.34M

246.86%1.33M

410.76%1.28M

--1.22M

--1.8M

--1.17M

--382K

--251K

Other net income (expense)

304.83%297K

142.93%762K

164.12%436K

133.74%391K

119.32%80K

-130.33%-145K

-478.46%-1.78M

-1,179.37%-680K

-4,392.59%-1.16M

-225.08%-414K

Other non- operating income (expenses)

304.83%297K

142.93%762K

164.12%436K

133.74%391K

119.32%80K

-130.33%-145K

-478.46%-1.78M

-1,179.37%-680K

-4,392.59%-1.16M

-225.08%-414K

Income before tax

-39.52%-33.91M

-5.21%-94.11M

-7.72%-26.88M

29.34%-17.51M

-28.68%-25.42M

-21.73%-24.3M

-10.21%-89.45M

-43.36%-24.96M

-27.83%-24.77M

26.40%-19.75M

Income tax

-2,054.55%-237K

142.84%787K

481.18%1.3M

66.75%-253K

64.02%-245K

80.00%-11K

-1,456.78%-1.84M

-96.53%-340K

-1,685.42%-761K

-4,964.29%-681K

Net income

-38.61%-33.67M

-8.32%-94.9M

-14.47%-28.18M

28.16%-17.25M

-31.99%-25.18M

-22.01%-24.29M

-8.10%-87.61M

-42.82%-24.62M

-23.59%-24.01M

28.97%-19.07M

Net income continuous Operations

-38.61%-33.67M

-8.32%-94.9M

-14.47%-28.18M

28.16%-17.25M

-31.99%-25.18M

-22.01%-24.29M

-8.10%-87.61M

-42.82%-24.62M

-23.59%-24.01M

28.97%-19.07M

Minority interest income

Net income attributable to the parent company

-38.61%-33.67M

-8.32%-94.9M

-14.47%-28.18M

28.16%-17.25M

-31.99%-25.18M

-22.01%-24.29M

-8.10%-87.61M

-42.82%-24.62M

-23.59%-24.01M

28.97%-19.07M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-38.61%-33.67M

-8.32%-94.9M

-14.47%-28.18M

28.16%-17.25M

-31.99%-25.18M

-22.01%-24.29M

-8.10%-87.61M

-42.82%-24.62M

-23.59%-24.01M

28.97%-19.07M

Basic earnings per share

11.11%-0.4

27.50%-1.45

29.09%-0.39

54.55%-0.25

13.64%-0.38

2.17%-0.45

-5.26%-2

-37.50%-0.55

-22.22%-0.55

30.16%-0.44

Diluted earnings per share

11.11%-0.4

27.50%-1.45

29.09%-0.39

54.55%-0.25

13.64%-0.38

2.17%-0.45

-5.26%-2

-37.50%-0.55

-22.22%-0.55

30.16%-0.44

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	41.55%2.07M	0	1,108.43%2.01M	-94.04%34K	-95.21%28K	1.46%1.46M	-76.43%140K	-48.92%166K	9.40%570K
Operating revenue	--0	41.55%2.07M	--0	1,108.43%2.01M	-94.04%34K	-95.21%28K	1.46%1.46M	-76.43%140K	-48.92%166K	9.40%570K
Cost of revenue
Gross profit
Operating expense	44.11%35.86M	13.19%101.3M	15.14%28.28M	-10.75%21.4M	34.70%26.75M	17.87%24.88M	7.24%89.5M	35.32%24.56M	20.82%23.97M	-28.54%19.86M
Selling and administrative expenses	61.54%14.55M	1.95%31.2M	9.76%7.63M	-8.22%6.81M	-0.36%7.75M	6.59%9.01M	12.92%30.6M	9.69%6.95M	3.69%7.42M	17.15%7.78M
-General and administrative expense	61.54%14.55M	1.95%31.2M	9.76%7.63M	-8.22%6.81M	-0.36%7.75M	6.59%9.01M	12.92%30.6M	9.69%6.95M	3.69%7.42M	17.15%7.78M
Research and development costs	34.23%21.31M	19.03%70.1M	17.27%20.65M	-11.88%14.59M	57.29%18.99M	25.40%15.88M	4.50%58.9M	49.07%17.61M	30.49%16.55M	-42.89%12.08M
Operating profit	-44.28%-35.86M	-12.72%-99.23M	-15.80%-28.28M	18.55%-19.39M	-38.50%-26.71M	-21.10%-24.86M	-7.34%-88.03M	-39.10%-24.42M	-21.98%-23.81M	29.27%-19.29M
Net non-operating interest income expense	137.25%1.66M	1,111.11%4.36M	582.86%956K	685.79%1.49M	2,388.68%1.21M	740.96%698K	-5.51%360K	72.84%140K	77.57%190K	-154.64%-53K
Non-operating interest income	82.61%3.51M	340.81%9.53M	75.23%2.29M	392.66%2.82M	1,160.10%2.5M	2,214.46%1.92M	467.19%2.16M	1,514.81%1.31M	434.58%572K	--198K
Non-operating interest expense	51.43%1.85M	186.84%5.17M	14.38%1.34M	246.86%1.33M	410.76%1.28M	--1.22M	--1.8M	--1.17M	--382K	--251K
Other net income (expense)	304.83%297K	142.93%762K	164.12%436K	133.74%391K	119.32%80K	-130.33%-145K	-478.46%-1.78M	-1,179.37%-680K	-4,392.59%-1.16M	-225.08%-414K
Other non- operating income (expenses)	304.83%297K	142.93%762K	164.12%436K	133.74%391K	119.32%80K	-130.33%-145K	-478.46%-1.78M	-1,179.37%-680K	-4,392.59%-1.16M	-225.08%-414K
Income before tax	-39.52%-33.91M	-5.21%-94.11M	-7.72%-26.88M	29.34%-17.51M	-28.68%-25.42M	-21.73%-24.3M	-10.21%-89.45M	-43.36%-24.96M	-27.83%-24.77M	26.40%-19.75M
Income tax	-2,054.55%-237K	142.84%787K	481.18%1.3M	66.75%-253K	64.02%-245K	80.00%-11K	-1,456.78%-1.84M	-96.53%-340K	-1,685.42%-761K	-4,964.29%-681K
Net income	-38.61%-33.67M	-8.32%-94.9M	-14.47%-28.18M	28.16%-17.25M	-31.99%-25.18M	-22.01%-24.29M	-8.10%-87.61M	-42.82%-24.62M	-23.59%-24.01M	28.97%-19.07M
Net income continuous Operations	-38.61%-33.67M	-8.32%-94.9M	-14.47%-28.18M	28.16%-17.25M	-31.99%-25.18M	-22.01%-24.29M	-8.10%-87.61M	-42.82%-24.62M	-23.59%-24.01M	28.97%-19.07M
Minority interest income
Net income attributable to the parent company	-38.61%-33.67M	-8.32%-94.9M	-14.47%-28.18M	28.16%-17.25M	-31.99%-25.18M	-22.01%-24.29M	-8.10%-87.61M	-42.82%-24.62M	-23.59%-24.01M	28.97%-19.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-38.61%-33.67M	-8.32%-94.9M	-14.47%-28.18M	28.16%-17.25M	-31.99%-25.18M	-22.01%-24.29M	-8.10%-87.61M	-42.82%-24.62M	-23.59%-24.01M	28.97%-19.07M
Basic earnings per share	11.11%-0.4	27.50%-1.45	29.09%-0.39	54.55%-0.25	13.64%-0.38	2.17%-0.45	-5.26%-2	-37.50%-0.55	-22.22%-0.55	30.16%-0.44
Diluted earnings per share	11.11%-0.4	27.50%-1.45	29.09%-0.39	54.55%-0.25	13.64%-0.38	2.17%-0.45	-5.26%-2	-37.50%-0.55	-22.22%-0.55	30.16%-0.44
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall